joannescott

There’s a fascinating article in the FT today about Daewoo’s plans to acquire half the arable land in Madagascar: Daewoo to pay nothing for vast land acquisition By Song Jung-a and Christian Oliver in Seoul and Tom,Burgis in Johannesburg Published: November 20 2008 02:00 | Last updated:

Two quick points in relation to the decision in Hormones II: I’ve always found it quite difficult to understand the distinction between scientific uncertainty and insufficiency of evidence in relation to Article 5.7. Does the AB do a better job of explaining it here (para. 677)? For the

Things are hotting up in relation to the EU's controversial chemicals regime. The Commission is poised to adopt a decision identifying the first substances of very high concern to be included in a so-called candidate list. If these substances are included on the 'final list for authorisation&

I've been away from the blog for some time, so I hope I haven't missed somebody else writing about this. It was interesting to note the US Environmental Protection Agency's decision not to allow the California waiver from the Clean Air Act, allowing CA

Still ploughing on with Biotech! I am struck today by the panel's (excessively) cautious approach to the interpretation of the special and differential treatment obligation in Article 10.1 of the SPS Agreement. The panel concluded that while Members must take the interests of developing countries into account

The well known British jornalist and political commentator, Martin Jacques, has a piece in today's GUARDIAN called 'The death of Doha Signals the Demise of Globalisation'.  He concludes that the deadlock in Doha is final and that it suggests not so much the end of globalisation

Like many of us, much of my summer is devoted to reading EC - Biotech! Today's chunk made me think again about the concept of an SPS measure. As many will know, the panel decided that the EC's de facto moratorium is not an SPS measure.

An appeal has been lodged in the Yusuf case (T-306/01), decided by the European Court of First Instance decided in September last year. The case is not about WTO Law, but is of interest to those following the EU/WTO direct effect saga before the European courts. Yusuf concerns

There is an interesting review of Sunstein's controversial book - The Laws of Fear - and a reply by Cass Sunstein in the Feb. issue of the Harvard Law Review. The review is by Paul Slovic among others and takes issue with Sunstein for ignoring cultural perceptions on

Ineresting story in yesterday's NEW YORK TIMES (p. A6). Bristol-Myers is to allow the newest and most powerful AIDS drug (atanazavir - a second line treatment for those who have developed resistance to their first anti-viral cocktails) to be licensed to generic drug makers in India and South